The Ministry of Public Health (MOPH) in a Tweet has mentioned that eligible individuals should not delay their COVID-19 Vaccine Booster Dose in Qatar.

يتوجب على الأفراد المؤهلين لتلقي الجرعة المعززة من التطعيم ضد كوفيد - ١٩ عدم التأخير في الحصول على التطعيم.

Eligible Individuals Should Not Delay Having Their COVID-19 Vaccine Booster Dose. pic.twitter.com/BILXwNwuJW

— وزارة الصحة العامة (@MOPHQatar) October 11, 2021

As per Dr. Soha Al Bayat, Head of Vaccination at MOPH, "It is clear from the latest clinical evidence that for most people the protective immunity obtained from the first two doses of the vaccine gradually begins to decline after eight months. Everyone currently eligible for a booster dose is considered to be at high risk of severe COVID-19 infection due to either their age or health status. For this reason, it is essential that people act quickly and come forward for their booster dose appointment when invited."

يتوجب على الأفراد المؤهلين لتلقي الجرعة المعززة من التطعيم ضد كوفيد - ١٩ عدم التأخير في الحصول على التطعيم.

Eligible Individuals Should Not Delay Having Their COVID-19 Vaccine Booster Dose. pic.twitter.com/DtvNGM0m57

— وزارة الصحة العامة (@MOPHQatar) October 11, 2021

In another Tweet, Dr. Samya Al Abdulla, Senior Consultant of Family Medicine and Executive Director of Operations at PHCC has said that "Clinical evidence from Qatar and around the world shows booster doses to be safe and effective. The risk of side effects following the booster vaccine dose is no higher than the risk associated with the primary vaccine series. Since the start of the National COVID-19 Vaccination Program, and following the administration of more than 4.7 million vaccine doses, we have only seen a small number of people reporting very mild or modest side effects including low-grade fever, mild headache, fatigue and soreness at the injection site, which is commonly seen with other vaccines."

Source: MOPH
Cover image source: Shutterstock

Follow us on our social media channels: @ILQlive @ILQlive @ILoveQtr ILoveQatar

Vrinda Abilash

Start a discussion